Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Retrieved on: 2021-05-03 06:00:49

Tags for this article:

Click the tags to see associated articles and topics

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment. View article details on hiswai:

Excerpt

Baricitinib, in combination with Remdesivir, is used for treatment of COVID-19 positive patients, a release from Natco on the approval said.

Article found on: www.thehindu.com